Company Filing History:

11 out of 1,697

New York University

where one patent can have more than one assignee

Years Active: 1995-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9939450 - Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments (2018-04-10),

2. 8883427 - Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments (2014-11-11),

3. 8420601 - Biocompatible materials containing stable complexes of TSG-6 and hyaluronan and method of using same (2013-04-16),

4. 8093365 - Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same (2012-01-10),

5. 6518401 - Tumor necrosis factor stimulated gene 6 (TSG-6) protein (2003-02-11),

6. 6313091 - Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method (2001-11-06),

7. 6210905 - Tumor necrosis factor stimulated gene 6 (TSG-6) binding molecules (2001-04-03),

8. 5846763 - DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6) (1998-12-08),

9. 5386013 - Tumor necrosis factor-induced protein TSG-6 (1995-01-31),

**Title: Hans-Georg Wisniewski: A Pioneer in Predictive Healthcare Innovations**

Introduction

Hans-Georg Wisniewski, an accomplished inventor based in Riverdale, NY, has made significant contributions to the field of healthcare through his innovative inventions. With a portfolio of nine patents, his work primarily focuses on methods for predicting disease progression and tailoring treatments for inflammatory conditions.

Latest Patents

One of Wisniewski's latest innovations revolves around quantifying local inflammatory activity. This method aims to predict the progression of inflammatory conditions in subjects by analyzing fluid samples. The process involves providing a medium containing hyaluronan, followed by the incubation of the fluid sample which contains proteins and proteoglycans. Utilizing a transfer agent, heavy chains are transferred to the hyaluronan, forming a complex that can be detected with antibodies. By comparing the levels of this complex to a reference standard, Wisniewski’s invention enables healthcare providers to track disease progression and make informed decisions about treatment options.

Career Highlights

Wisniewski has had a remarkable career, showcasing his talents at reputable institutions like New York University and the Polytechnic Institute of New York University. Through his roles in these organizations, he has contributed to the advancement of scientific knowledge and innovative healthcare solutions.

Collaborations

Throughout his career, Wisniewski has collaborated with esteemed colleagues such as Jan T. Vilcek and Philip A. Band. These collaborations have enriched his research efforts, combining their expertise to push the boundaries of healthcare innovation.

Conclusion

Hans-Georg Wisniewski stands as a notable figure in the landscape of healthcare advancements. His innovative patents not only enhance our understanding of inflammatory conditions but also provide practical methods to improve patient outcomes. As the field of predictive healthcare continues to evolve, Wisniewski's contributions will undoubtedly have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com